Showing results (21-30 of 133) with videos related to
Sort By:
Pageof 14
Endocrinology|February 15, 2003
The signaling adapters fibroblast growth factor receptor substrate 2 and 3 are activated by the thyroid TRK oncoproteinsValeria Ranzi, Susan O Meakin, Claudia Miranda, et al.Tumori|February 11, 2012
Cancer research performance in the European Union: a study of published output from 2000 to 2008Andrea Micheli, Francesca Di Salvo, Claudio Lombardo, et al.Oncogene|February 14, 2003
Role of TFG sequences outside the coiled-coil domain in TRK-T3 oncogenic activationEmanuela Roccato, Sonia Pagliardini, Loredana Cleris, et al.Cancer Research|April 5, 2005
Proximity of TPR and NTRK1 rearranging loci in human thyrocytesEmanuela Roccato, Paola Bressan, Guido Sabatella, et al.Expert Opinion on Therapeutic Targets|March 7, 2013
RET inhibition: implications in cancer therapyMaria Grazia Borrello, Elena Ardini, Laura D Locati, et al.Tumori|July 8, 2009
Italian performance in cancer researchAndrea Micheli, Francesca Di Salvo, Claudio Lombardo, et al.Journal of Cellular Physiology|May 28, 2015
The Effects of miR-20a on p21: Two Mechanisms Blocking Growth Arrest in TGF-β-Responsive Colon CarcinomaViktorija Sokolova, Antonio Fiorino, Eugenio Zoni, et al.Breast Cancer Research and Treatment|August 12, 2003
HER-2/neu assessment in primary chemotherapy treated breast carcinoma: no evidence of gene profile changingGian Paolo Dagrada, Alessandra Mezzelani, Loredana Alasio, et al.The Journal of Biological Chemistry|November 24, 2001
Novel pathogenic mechanisms of congenital insensitivity to pain with anhidrosis genetic disorder unveiled by functional analysis of neurotrophic tyrosine receptor kinase type 1/nerve growth factor receptor mutationsClaudia Miranda, Michela Di Virgilio, Silvia Selleri, et al.The International Journal of Biological Markers|February 24, 2015
Moving from discovery to validation in circulating microRNA researchPaolo Verderio, Stefano Bottelli, Chiara M Ciniselli, et al.Pageof 14